Trial Profile
Characterization Of The Use Of Ceftolozane/Tazobactam At A Health System With A Large Academic Medical Center
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2016
Price :
$35
*
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Bacteraemia; Intra-abdominal infections; Pneumonia
- Focus Therapeutic Use
- 31 Dec 2016 New trial record